EIN 95-3432210

Beckman Research Institute of the City of Hope (BRI)

IRS 501(c) type
501(c)(3)
Num. employees
1,248
City
Year formed
1979
Most recent tax filings
2023-09-01
NTEE code, primary
Description
Beckman Research Institute of City of Hope was the first of five Beckman Institutes to be founded, and has held a National Cancer Institute Cancer Center Support Grant for over 30 years.
Also known as...
Beckman Research Institute of City of Hope
Total revenues
$229,086,534
2023
Total expenses
$353,496,343
2023
Total assets
$1,946,470,774
2023
Num. employees
1,248
2023

Program areas at BRI

Biomedical Research and disease investigations, including dna synthesis and cell analysis. Beckman Research Institute has pioneered scientific breakthroughs resulting in treatments that have improved the lives of patients worldwide. Numerous life-saving drugs use patented technology developed at Beckman Research Institute. These drugs include synthetic human insulin (humulin) for diabetes, the widely used cancer drugs herceptin, rituxan and avastin, and humira for arthritis. Researchers at Beckman Research Institute undertake fundamental investigations in diabetes progression and treatment, immunology and imaging, interfering rnas and hiv treatment, total synthesis of complex and therapeutic natural products, mechanisms of drug action, neurogenesis, stem cell therapy, dna repair and radiation, and the immunobiology of viral infection. They have achieved major advances in recombinant dna technology, monoclonal antibodies, gene therapy, epigenetics, si-rna technology and cancer immunotherapeutics. A department in Beckman Research Institute is dedicated to understanding and developing treatments based on cancer's interaction with the immune system. Other Research has identified proteins that may play critical roles in immune response and may lead to new treatment strategies. Another major emphasis for the Beckman Research Institute scientists is personalized Research and medicine -- analyzing a patient's unique genetic profile to develop tailored therapies for their specific disease. All of this Research is uniquely supported by onsite manufacturing facilities that can test and produce quantities of cell-based, gene-based and molecular therapies. These facilities further serve as resources for medical and scientific Research centers nationwide. Beckman Research Institute scientists serve as faculty members in City of Hope's irell & manella graduate school of biological sciences. the graduate school's mission is to train students to be outstanding Research scientists in chemical, molecular and cellular biology. the school is accredited by the western association of schools and colleges. Graduates of the program, awarded a doctorate of philosophy in biological sciences, are equipped to address fundamental questions in life sciences and biomedicine for careers in academia, industry and government.

Who funds Beckman Research Institute of the City of Hope (BRI)

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
City of HopeOperating Support$43,883,442
Juvenile Diabetes Research Foundation (JDRF)Beta Cell Regeneration$2,559,923
Arnold and Mabel Beckman FoundationResearch, General Support & Education$1,817,000
...and 33 more grants received totalling $52,235,529

Personnel at BRI

NameTitleCompensation
Robert StoneChief Executive Officer$1,079,108
Angelique L. Richard, Ph.D., R.N.Chief Operating Officer , City of Hope National Medical Center
Yvette TremontiTreasurer and Chief Financial Officer
Ken ChaplinSystem Chief Marketing Officer
Simon NazarianSystem Executive Vice President and Chief Digital and Technology Officer
...and 24 more key personnel

Financials for BRI

RevenuesFYE 09/2023
Total grants, contributions, etc.$150,737,172
Program services$15,969,208
Investment income and dividends$13,528,631
Tax-exempt bond proceeds$0
Royalty revenue$8,998,487
Net rental income$61,700
Net gain from sale of non-inventory assets$35,158,934
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$4,632,402
Total revenues$229,086,534

Form 990s for BRI

Fiscal year endingDate received by IRSFormPDF link
2023-092024-08-13990View PDF
2022-092023-08-15990View PDF
2021-092022-08-11990View PDF
2020-092021-08-12990View PDF
2019-092020-10-08990View PDF
...and 10 more Form 990s
Data update history
October 4, 2024
Updated personnel
Identified 7 new personnel
September 24, 2024
Posted financials
Added Form 990 for fiscal year 2023
September 22, 2024
Used new vendors
Identified 2 new vendors, including , and
September 21, 2024
Updated personnel
Identified 3 new personnel
September 21, 2024
Received grants
Identified 15 new grant, including a grant for $43,883,442 from City of Hope
Nonprofit Types
Medical research organizationsResearch centersHeadquarter / parent organizationsCharities
Issues
Science and technologyHealthDiseases and disorders
Characteristics
Conducts researchLobbyingOperates internationallyReceives government fundingEndowed supportTax deductible donations
General information
Address
1450 E Duarte Rd
Duarte, CA 91010
Metro area
Los Angeles-Long Beach-Anaheim, CA
County
Los Angeles County, CA
Phone
(626) 256-4673
IRS details
EIN
95-3432210
Fiscal year end
September
Taxreturn type
Form 990
Year formed
1979
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H30: Cancer Research
NAICS code, primary
5417: Scientific Research and Development Services
Parent/child status
Central organization
California AB-488 details
AB 488 status
May Operate or Solicit for Charitable Purposes
Charity Registration status
Exempt
FTB status revoked
Not revoked
AG Registration Number
040151
FTB Entity ID
0946473
AB 488 data last updated ("as-of") date
2024-12-04
Free account sign-up

Want updates when BRI has new information, or want to find more organizations like Beckman Research Institute of the City of Hope (BRI)?

Create free Cause IQ account